U.S. FDA approves Amgen heart failure drug
April 15, 2015 at 16:46 PM EDT
April 15 (Reuters) - U.S. health regulators on Wednesday approved Amgen Inc's Corlanor to treat patients with chronic heart failure, giving the world's largest biotechnology company its first cardiovascular medicine product.